# Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)

Study · id `cardio:ct-nct02391337` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02391337](<https://clinicaltrials.gov/study/NCT02391337>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02391337

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

## Technical summary

Registry record NCT02391337. Randomized; no masking; primary purpose treatment. Start 2016-12-20 (actual); primary completion 2019-04-15 (actual). Results posted on 2021-06-16.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 161 participants (enrolled count; ClinicalTrials.gov record NCT02391337, source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)
- Started: 2016-12-20 (actual) (ClinicalTrials.gov record NCT02391337, source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)
- Primary completion: 2019-04-15 (actual) (ClinicalTrials.gov record NCT02391337, source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)
- Completion: 2019-09-16 (actual) (ClinicalTrials.gov record NCT02391337, source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)
- Results first posted: 2021-06-16 (ClinicalTrials.gov record NCT02391337, source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02391337, source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02391337-2021-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
- Acronym: RATE-AF
- Condition: Permanent Atrial Fibrillation
- Intervention (Drug): Bisoprolol
- Intervention (Drug): Digoxin
- Lead sponsor: University of Birmingham
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Bisoprolol (`cardio:bisoprolol`)
- Registry lists this organization as the lead sponsor: University of Birmingham (`cardio:org-university-of-birmingham`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial (`cardio:pubmed-33351042`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial (`cardio:pubmed-39009776`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial (`cardio:pubmed-39819610`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Quantification and impact of circulating cardiotonic steroids in the RATE-AF randomised trial of patients with atrial fibrillation and heart failure (`cardio:pubmed-41462450`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c7f0980a8ed1f1b1615b3f2974b8b467113392efbedae63ed37ad145e8c62dc8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
